Pediatric Hematology & Oncology
A section of Children (ISSN 2227-9067).
Section Information
The Pediatric Hematology & Oncology Section accepts articles related to the diagnosis and treatment of benign hematologic conditions, childhood and adolescent cancers, and hematopoietic stem cell transplantation for benign and malignant conditions. Articles can focus on therapy, supportive care, long-term outcomes/survivorship, epidemiology and disease prevention, and the economic impact of these diseases (both on the patient and the health care system). Clinical trials and observational studies (cohort studies, case-control studies) are preferred, but systematic reviews/meta-analyses are also welcome as long as they are methodologically rigorous. Case reports will only be considered if they report on a novel finding with important clinical implications.
- Childhood cancer
- Benign hematology
- Hematopoietic stem cell transplant
- Adolescents
- Survivorship/late effects
- Health economics
- Health services research
- Clinical trials
- Solid tumors
- Brain tumors
- Leukemia and lymphoma
- Thrombosis and hemostasis
- Hemoglobinopathies
- Bone marrow failure syndromes
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Advances in the Epidemiology of Hemostasis Disorders in Children (Deadline: 30 May 2026)
- Immunotherapy for Childhood Cancer: Current Trends and Future Perspectives (Deadline: 5 July 2026)
- Acute Lymphoblastic Leukemia Novel Therapeutic Approaches and Clinical Implications (Deadline: 25 July 2026)
- Diagnosis, Treatment, and Prevention of Anemia in Children (Deadline: 5 August 2026)
- Psychological Support in Pediatric Oncology: Improving Clinical Outcomes and Quality of Life (Deadline: 10 August 2026)
- Advances in Neonatal Hematology and Hemostasis (Deadline: 30 August 2026)
